Valuation: Baxter International Inc.

Market Cap 13.35B 12.1B 11.19B 10.1B 19.03B 1,259B 19.7B 134B 53.31B 673B 50.11B 49.05B 2,135B P/E 2026 *
20.8x
P/E 2027 * 18.9x
Enterprise Value 20.18B 18.29B 16.92B 15.26B 28.76B 1,903B 29.78B 203B 80.58B 1,017B 75.74B 74.13B 3,227B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.63x
Free-Float
75.44%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day+0.27%
1 week+0.08%
Current month+12.22%
1 month+3.70%
3 months-4.58%
6 months+49.10%
Current year+35.06%
1 week 25.43
Extreme 25.43
26.71
1 month 22.5
Extreme 22.495
27.08
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Chief Tech/Sci/R&D Officer 57 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Other

EVP and CFO

0 0.0000% -
9/2/26 Tax

President, Front Line Care

-2,098 0.0004%
9/2/26 Tax

Chief Executive Officer

-54,276 0.0105%
Change 5-day change 1-year change 3-year change Capi.($)
+0.27%+0.08%+38.02%-23.44% 13.32B
+1.18%-1.28%-16.05%+13.29% 186B
+1.85%+1.04%+6.99%+42.70% 124B
-0.88%-4.98%-17.08%+9.86% 119B
+1.36%-5.91%-43.00%+3.16% 91.43B
+2.96%+7.64%-1.76%+80.54% 66.67B
+1.08%+2.90%+12.95%-7.56% 58.76B
+0.89%+4.17%+0.39%+62.87% 54.99B
-0.68%+6.83%-1.64%+55.26% 49.93B
-1.28%-0.43% - - 35.13B
Average +0.40%-1.71%-2.35%+26.30% 80B
Weighted average by Cap. +0.45%-3.26%-9.16%+26.25%

Financials

2026 *2027 *
Net sales 11.72B 10.62B 9.83B 8.87B 16.71B 1,105B 17.3B 118B 46.81B 591B 44B 43.06B 1,874B 11.96B 10.84B 10.02B 9.04B 17.05B 1,128B 17.65B 120B 47.75B 602B 44.88B 43.93B 1,912B
Net income 621M 563M 520M 470M 885M 58.54B 916M 6.25B 2.48B 31.27B 2.33B 2.28B 99.27B 601M 545M 504M 455M 857M 56.7B 887M 6.05B 2.4B 30.29B 2.26B 2.21B 96.14B
Net Debt 6.83B 6.19B 5.72B 5.17B 9.73B 644B 10.08B 68.77B 27.27B 344B 25.63B 25.09B 1,092B 6.14B 5.57B 5.15B 4.65B 8.76B 579B 9.06B 61.86B 24.53B 309B 23.06B 22.57B 982B
Projected Income Statement - Annual - Baxter International Inc.
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-11-13 US$25.81 +0.27% 4,491,215
26-11-12 US$25.74 -2.28% 4,668,666
26-11-11 US$26.34 -0.30% 3,826,031
26-11-10 US$26.42 +0.04% 3,830,324
26-11-09 US$26.41 +2.40% 4,538,672
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Baxter International Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
25.81USD
Average target price
27.25USD
Spread / Average Target
+5.58%